SEC Form 4 · accession 0001209191-16-103090

Veradigm Inc. · MDRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).

Reporting owner

Officer — SVP Gerneral Counsel & Corpora

Period of report

Feb 24, 2016

Accepted (ET)

Feb 26, 2016 · 6:29 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001124804

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 24, 2016	A	52,462	$0.00	A	155,967	D
Common Stock	Feb 24, 2016	F	2,383	$12.39	D	153,584	D
Common Stock	Feb 24, 2016	A	2,251	$0.00	A	155,835	D
Common Stock	Feb 24, 2016	F	679	$12.39	D	155,156	D

No Table II lines on this filing.

F1Award of service-based Restricted Stock Units granted under the Allscripts Healthcare Solutions, Inc. 2011 Stock Incentive Plan on February 24, 2016 (the "Grant Date"). The award vests 33% per year on each of the first three anniversaires of the date of grant, subject to achievement of a performance goal for the period ending December 31, 2016.
F2Withholding shares solely to cover withholding tax liabilities in connection with the vesting of performance stock units on February 24, 2016.
F3On February 25, 2014 (the "Grant Date"), the reporting person was granted performance-based restricted stock units ("PSUs"), the vesting of which was subject to both continued service and performance measure of a combination of 50% non-GAAP adjusted EBITDA and 50% non-GAAP revenue targets were attained for each of the three annual periods commencing on the Grant Date. The acquisition of shares of the Issuer's common stock represents the vesting of PSUs for the performance period ending one year from the Grant Date.